Newswise News from The Lancet Latest news from The Lancet on Newswise en-us Copyright 2024 Newswise Newswise News from The Lancet 115 31 / /images/newswise-logo-rss.gif THE LANCET PLANETARY HEALTH: Experts warn 'green growth' in high income countries is not happening, call for 'post-growth' climate policies to meet Paris targets /articles/lancet-post-growth-climate-policies-urgent/?sc=rsin /articles/lancet-post-growth-climate-policies-urgent/?sc=rsin Tue, 05 Sep 2023 14:05:03 EST The emission reductions in the 11 high-income countries that have "decoupled" CO2 emissions from Gross Domestic Product (GDP) fall far short of the reductions that are necessary to limit global warming to 1.5 deg.C or even just to "well below 2 deg.C" and comply with international fairness principles. The Lancet Minimum unit pricing for alcohol associated with a 13% decrease in deaths from alcohol consumption in Scotland, study suggests /articles/minimum-alcohol-price-linked-to-13-reduction-in-alcohol-deaths/?sc=rsin /articles/minimum-alcohol-price-linked-to-13-reduction-in-alcohol-deaths/?sc=rsin Wed, 19 Apr 2023 15:25:20 EST The implementation of minimum unit pricing (MUP) legislation is associated with significant reductions in alcohol-specific deaths among those from the most socio-economically deprived areas in Scotland, suggests a new study published in The Lancet. The Lancet In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial /articles/in-vivo-t-cell-depleted-reduced-intensity-conditioned-allogeneic-haematopoietic-stem-cell-transplantation-for-patients-with-acute-lymphoblastic-leukaemia-in-first-remission-results-from-the-prospective-single-arm-evaluation-of-the-ukall14-trial/?sc=rsin /articles/in-vivo-t-cell-depleted-reduced-intensity-conditioned-allogeneic-haematopoietic-stem-cell-transplantation-for-patients-with-acute-lymphoblastic-leukaemia-in-first-remission-results-from-the-prospective-single-arm-evaluation-of-the-ukall14-trial/?sc=rsin Fri, 01 Apr 2022 09:00:31 EST Background The outcome of chemotherapy in patients older than 40 years with acute lymphoblastic leukaemia is poor and myeloablative allogeneic haematopoietic stem-cell transplantation (HSCT) has a high transplant-related ... The Lancet Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access /articles/lentiviral-haematopoietic-stem-cell-gene-therapy-for-early-onset-metachromatic-leukodystrophy-long-term-results-from-a-non-randomised-open-label-phase-12-trial-and-expanded-access/?sc=rsin /articles/lentiviral-haematopoietic-stem-cell-gene-therapy-for-early-onset-metachromatic-leukodystrophy-long-term-results-from-a-non-randomised-open-label-phase-12-trial-and-expanded-access/?sc=rsin Mon, 24 Jan 2022 08:55:50 EST ... Evidence of allogeneic haematopoietic stem-cell transplantation being beneficial in patients with late-infantile MLD appears to be very ... Furthermore, allogeneic haematopoietic stem-cell transplantation did not slow down disease progression in ... The Lancet